Depression's link with CVD and mortality especially marked in urban areas

Organisation: Position: Deadline Date: Location:

In this 21-nation, population-based cohort study, adults with depressive symptoms were associated with having increased risk of cardiovascular disease (CVD) and mortality in economically diverse settings, especially in urban areas.

In the Prospective Urban Rural Epidemiology (PURE) Study, investigators from 21 countries and 145,862 participants, cardiovascular events and death increased by 20% in people with 4 or more depressive symptoms compared with people without. The investigators – including those from the London School of Hygiene & Tropical Medicine, Hamilton Health Sciences and McMaster University, Sahlgrenska Academy, Sahlgrenska University Hospital, University of Gothenburg, Eternal Heart Care Centre & Research Institute – Jaipur, University of Ottawa, University of Zimbabwe College of Health Sciences, Wroclaw Medical Universit, and the North-West University-Potchefstroom – found that relative risk increased in countries at all economic levels but was more than twice as high in urban than rural areas.

Adults with depressive symptoms experience poor physical health outcomes and increased risk of mortality across the world and in different settings, especially in urban areas.

Importance: Depression is associated with incidence of and premature death from cardiovascular disease (CVD) and cancer in high-income countries, but it is not known whether this is true in low- and middle-income countries and in urban areas, where most people with depression now live.
Objective: To identify any associations between depressive symptoms and incident CVD and all-cause mortality in countries at different levels of economic development and in urban and rural areas.
Design, Setting, and Participants: This multicenter, population-based cohort study was conducted between January 2005 and June 2019 (median follow-up, 9.3 years) and included 370 urban and 314 rural communities from 21 economically diverse countries on 5 continents. Eligible participants aged 35 to 70 years were enrolled. Analysis began February 2018 and ended September 2019.
Exposures: Four or more self-reported depressive symptoms from the Short-Form Composite International Diagnostic Interview.
Main Outcomes and Measures: Incident CVD, all-cause mortality, and a combined measure of either incident CVD or all-cause mortality.
Results: Of 145 862 participants, 61 235 (58%) were male and the mean (SD) age was 50.05 (9.7) years. Of those, 15 983 (11%) reported 4 or more depressive symptoms at baseline. Depression was associated with incident CVD (hazard ratio [HR], 1.14; 95% CI, 1.05-1.24), all-cause mortality (HR, 1.17; 95% CI, 1.11-1.25), the combined CVD/mortality outcome (HR, 1.18; 95% CI, 1.11-1.24), myocardial infarction (HR, 1.23; 95% CI, 1.10-1.37), and noncardiovascular death (HR, 1.21; 95% CI, 1.13-1.31) in multivariable models. The risk of the combined outcome increased progressively with number of symptoms, being highest in those with 7 symptoms (HR, 1.24; 95% CI, 1.12-1.37) and lowest with 1 symptom (HR, 1.05; 95% CI, 0.92 -1.19; P for trend < .001). The associations between having 4 or more depressive symptoms and the combined outcome were similar in 7 different geographical regions and in countries at all economic levels but were stronger in urban (HR, 1.23; 95% CI, 1.13-1.34) compared with rural (HR, 1.10; 95% CI, 1.02-1.19) communities (P for interaction = .001) and in men (HR, 1.27; 95% CI, 1.13-1.38) compared with women (HR, 1.14; 95% CI, 1.06-1.23; P for interaction < .001).
Conclusions and Relevance: In this large, population-based cohort study, adults with depressive symptoms were associated with having increased risk of incident CVD and mortality in economically diverse settings, especially in urban areas. Improving understanding and awareness of these physical health risks should be prioritized as part of a comprehensive strategy to reduce the burden of noncommunicable diseases worldwide.

Selina Rajan; Martin McKee; Sumathy Rangarajan; Shrikant Bangdiwala; Annika Rosengren; Rajeev Gupta Vellappillil Raman Kutty; Andreas Wielgosz; Scott Lear; Khalid F AlHabib; Homer U Co; Patricio Lopez-Jaramillo; Alvaro Avezum; Pamela Seron; Aytekin Oguz; Iolanthé M Kruger; Rafael Diaz; Mat-Nasir Nafiza; Jephat Chifamba; Karen Yeates; Roya Kelishadi; Wadeia Mohammed Sharief; Andrzej Szuba; Rasha Khatib; Omar Rahman; Romaina Iqbal; Hu Bo; Zhu Yibing; Li Wei; Salim Yusuf


JAMA abstract

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.